BIOHAVEN PHARMACTL HLDG CO L's ticker is and the CUSIP is G11196955. A total of 4 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,321,000 | +170.5% | 35,200 | +160.7% | 0.01% | +233.3% |
| Q2 2022 | $1,967,000 | -41.2% | 13,500 | -52.1% | 0.00% | 0.0% |
| Q1 2022 | $3,344,000 | +26.4% | 28,200 | +46.9% | 0.00% | +50.0% |
| Q4 2021 | $2,646,000 | +90.5% | 19,200 | +92.0% | 0.00% | 0.0% |
| Q3 2021 | $1,389,000 | +210.7% | 10,000 | +117.4% | 0.00% | +100.0% |
| Q2 2021 | $447,000 | -73.2% | 4,600 | -81.1% | 0.00% | -50.0% |
| Q1 2021 | $1,668,000 | -74.8% | 24,400 | -68.4% | 0.00% | -81.8% |
| Q4 2020 | $6,617,000 | +44.8% | 77,200 | +9.8% | 0.01% | -21.4% |
| Q3 2020 | $4,570,000 | +126.5% | 70,300 | +154.7% | 0.01% | +55.6% |
| Q2 2020 | $2,018,000 | +47.5% | 27,600 | -31.3% | 0.01% | -18.2% |
| Q1 2020 | $1,368,000 | -38.1% | 40,200 | -1.0% | 0.01% | -26.7% |
| Q4 2019 | $2,210,000 | -65.5% | 40,600 | -73.6% | 0.02% | -71.2% |
| Q3 2019 | $6,404,000 | -41.7% | 153,500 | -38.8% | 0.05% | -47.5% |
| Q2 2019 | $10,978,000 | +241.8% | 250,700 | +301.8% | 0.10% | +175.0% |
| Q1 2019 | $3,212,000 | +98.3% | 62,400 | +42.5% | 0.04% | +157.1% |
| Q4 2018 | $1,620,000 | +169.6% | 43,800 | +173.8% | 0.01% | +180.0% |
| Q3 2018 | $601,000 | -31.2% | 16,000 | -27.6% | 0.01% | -28.6% |
| Q2 2018 | $873,000 | -64.6% | 22,100 | -76.9% | 0.01% | -72.0% |
| Q1 2018 | $2,463,000 | – | 95,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 10,000 | $1,389,000 | 0.00% |
| JPMORGAN CHASE & CO | 30,000 | $4,167,000 | 0.00% |
| SIMPLEX TRADING, LLC | 1,700 | $169,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |